# Biologic Lung Volume Reduction (BLVR) Phase 2 Homogeneous Study

> **NCT00630227** · PHASE2 · COMPLETED · sponsor: **Aeris Therapeutics** · enrollment: 33 (actual)

## Conditions studied

- Homogeneous Emphysema

## Interventions

- **BIOLOGICAL:** Biologic Lung Volume Reduction

## Key facts

- **NCT ID:** NCT00630227
- **Lead sponsor:** Aeris Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2011-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00630227

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00630227, "Biologic Lung Volume Reduction (BLVR) Phase 2 Homogeneous Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00630227. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*